Smoking Increases Risk of Fatal Prostate Cancer
Recent cigarette smoking is associated with an increased risk of fatal prostate cancer, according to a new report.
Diagnosis & Disease Information
Drug’s Ability to Lower Prostate Cancer Risk Confirmed
In a study, dutasteride had a protective effect regardless of baseline variables known to affect risk.
Prostate-Sparing Cystectomy Is Safe
This approach has oncologic outcomes similar to that of standard cystoprostatectomy, study shows.
The Risks and Rewards of Owning Gold
Investors incur risks when they own precious metals, but the returns can outpace the S&P 500.
Medical Errors Linked to Fatigue, Emotional Distress
Internal medicine residents who report higher levels of fatigue and emotional distress also report higher levels of major medical errors, according to a recent study reported in the Journal of the American Medical Association, (2009;302:1294-1300).
Courts to Decide Legitimacy Of Malpractice Award Caps
Four state supreme courts are set to decide whether to do away with caps on non-economic damages in malpractice cases.
Certificate of Merit Requirement Overturned
The Washington State Supreme Court has overturned the state’s certificate of merit requirement for malpractice suits.
Institute Is Awarded DoD Grant For Prostate Cancer Drug Research
The U.S. Department of Defense/Prostate Cancer Research Program (DoD/PCRP) has awarded a $1.55 million grant to SRI International, a nonprofit research institute based in Menlo Park, Calif., to support product-driven, preclinical studies of novel agents that have the potential to become prostate cancer drugs.
Lithostat for Struvite Stones Reintroduced
Lithostat (acetohydroxamic acid), the only urease inhibitor available for urea-splitting urinary infections in association with struvite stones, is available again at pharmacies nationwide, according to the drug’s marketer, Mission Pharmacal.
Telmisartan Okayed for Cardiovascular Risk Reduction
Boehringer Ingelheim Pharmaceuticals has received approval for a new indication for its angiotensin II receptor blocker Micardis (telmisartan).
- Loading...
Loading...
Next post in Cardiovascular Disease (CVD)
Loading... 
Loading...